Liver Transplantation for NASH
Topics
Meeting category
Date(s)
14 Nov 2016
Location
Boston, United States
Platinum Level Support
Sponsor logos
intercept

Symposium on Key Issues in Liver Transplantation for NASH 2016

Related Enduring Materials

Enduring Materials
Session 1: Pre -Transplant Issues -
Moderators
Michael Charlton
Michael Charlton, MD
Intermountain Medical Center, USA
Greg Everson
Greg Everson, MD
University of Colorado Denver, USA
What is an acceptable BMI
Lee Kaplan
Lee Kaplan, MD, PhD
Massachusetts General Hospital, USA
Can Bariatric surgery convert a non-candidate to a candidate?
placeholder3
Julie Heimbachx, MD
Myao Clinic, USA
Session 2: Post-Transplant Issues -
Moderators
Russel Wiesner
Russel Wiesner, MD
Mayo Clinic Minnesota, USA
Arun Sanyal
Arun Sanyal
Virginia Commonwealth University, USA
How should we optimize immunosuppression?
placeholder3
Kittie Wynne, MD, PhD
Wexner Medical Center, USA
Panel Discussion
Overview
Welcome

The Symposium on Key Issues in Liver Transplantation for NASH, was held on14 November 2016 during the AASLD in Boston, MA, USA.

This symposium was designed to address key issues in the pre- and post-transplant management of the liver transplant candidate with NASH. Emphasis was placed on assessment and management of metabolic complications and cardiovascular disease. A primary goal of the workshop was to define controversial issues in pre-transplant evaluation, management and treatment of NASH and to review critical issues in post-transplant management to optimize graft function and patient outcome.

Yours sincerely,

Program Directors

Program Directors
Greg Everson
Greg Everson, MD, FACP
University of Colorado Denver, USA
Arun Sanyal
Arun Sanyal, MD, MBBS
Virginia Commonwealth University, USA